“Biochip development continued during the Quarter with a biosensing graphene transistor
design sent to a commercial foundry to make the devices on a multi-project wafer. The goal is
to optimise the design and then select the design that works the best and can be easily scaled
up for commercial production. By the end of 2023, the Company should receive the first batch
of chips from the foundry.”
Ann: Quarterly Activity Report & Appendix 4C, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AXE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.71M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 26.0¢ | 24.0¢ | $34.29K | 136.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36729 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 7367 | 4 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| AXE (ASX) Chart |